Yu Kuboyama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yu Kuboyama has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Junichi Mazaki
Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University, Tokyo, Japan
1 shared publication - Kenichi Iwasaki
Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University, 6-7-1 Nishi-Shinjuku, Shinjuku 160-0023, Tokyo, Japan
1 shared publication - Kenta Kasahara
Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University, Tokyo, Japan
1 shared publication - Masahiro Sugimoto
Institute for Advanced Biosciences, Keio University, Tsuruoka 997-0052, Japan
1 shared publication - Ryutaro Udo
Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University, 6-7-1 Nishi-Shinjuku, Shinjuku 160-0023, Tokyo, Japan
1 shared publication - Tetsuo Ishizaki
Tokyo Medical University
1 shared publication
Latest Publications
- Open Access
- 2 September 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (17) , 5202
Stage-Specific Plasma Metabolomic Profiles in Colorectal Cancer
Background/Objectives: The objective of this study was to investigate the metabolomic profiles of patients with colorectal cancer (CRC) across various stages of the disease. Methods: The plasma samples were obtained from 255 subjects, including patients with CRC in stages I-IV, polyps, and controls. We employed capillary electrophoresis time-of-flight mass spectrometry and liquid chromatography triple quadrupole mass spectrometry to analyze hydrophilic metabolites comprehensively. The data were randomly divided into two groups, and consistent differences observed in both groups were analyzed. Results: Acetylated polyamines, such as N1-acetylspermine and N1, N12-diacetylspermine, consistently showed elevated concentrations in stage IV compared to stages I-III. Non-acetylated polyamines, including spermine and spermidine, exhibited increasing trends from polyp to stage IV. Other metabolites, such as histidine and o-acetylcarnitine, showed decreasing trends across stages. While acetylated polyamines have been reported as CRC detection markers, our findings suggest that they also possess diagnostic potential for distinguishing stage IV from other stages. Conclusions: This study showed stage-specific changes in metabolic profiles, including polyamines, of colorectal cancer.
- 2 September 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (17) , 5202
Open AccessStage-Specific Plasma Metabolomic Profiles in Colorectal Cancer
Background/Objectives: The objective of this study was to investigate the metabolomic profiles of patients with colorectal cancer (CRC) across various stages of the disease. Methods: The plasma samples were obtained from 255 subjects, including patients with CRC in stages I-IV, polyps, and controls. We employed capillary electrophoresis time-of-flight mass spectrometry and liquid chromatography triple quadrupole mass spectrometry to analyze hydrophilic metabolites comprehensively. The data were randomly divided into two groups, and consistent differences observed in both groups were analyzed. Results: Acetylated polyamines, such as N1-acetylspermine and N1, N12-diacetylspermine, consistently showed elevated concentrations in stage IV compared to stages I-III. Non-acetylated polyamines, including spermine and spermidine, exhibited increasing trends from polyp to stage IV. Other metabolites, such as histidine and o-acetylcarnitine, showed decreasing trends across stages. While acetylated polyamines have been reported as CRC detection markers, our findings suggest that they also possess diagnostic potential for distinguishing stage IV from other stages. Conclusions: This study showed stage-specific changes in metabolic profiles, including polyamines, of colorectal cancer.